IL134151A0 - Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity - Google Patents

Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity

Info

Publication number
IL134151A0
IL134151A0 IL13415198A IL13415198A IL134151A0 IL 134151 A0 IL134151 A0 IL 134151A0 IL 13415198 A IL13415198 A IL 13415198A IL 13415198 A IL13415198 A IL 13415198A IL 134151 A0 IL134151 A0 IL 134151A0
Authority
IL
Israel
Prior art keywords
controlled release
oral cavity
polymer compositions
pharmaceutical agents
tannic acid
Prior art date
Application number
IL13415198A
Other languages
English (en)
Original Assignee
Perio Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Perio Prod Ltd filed Critical Perio Prod Ltd
Publication of IL134151A0 publication Critical patent/IL134151A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL13415198A 1997-07-23 1998-07-22 Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity IL134151A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US89912197A 1997-07-23 1997-07-23
PCT/US1998/015096 WO1999004764A1 (en) 1997-07-23 1998-07-22 Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity

Publications (1)

Publication Number Publication Date
IL134151A0 true IL134151A0 (en) 2001-04-30

Family

ID=25410514

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13415198A IL134151A0 (en) 1997-07-23 1998-07-22 Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity

Country Status (10)

Country Link
EP (1) EP1003483A1 (hu)
JP (1) JP2001510788A (hu)
KR (1) KR20010021911A (hu)
AU (1) AU8578498A (hu)
BR (1) BR9811478A (hu)
CA (1) CA2296654A1 (hu)
HU (1) HUP0002490A2 (hu)
IL (1) IL134151A0 (hu)
NO (1) NO20000284L (hu)
WO (1) WO1999004764A1 (hu)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0301465A3 (en) * 2000-06-23 2006-07-28 Teva Pharma Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
US6476006B2 (en) 2000-06-23 2002-11-05 Teva Pharmaceutical Industries, Ltd. Composition and dosage form for delayed gastric release of alendronate and/or other bis-phosphonates
US7674480B2 (en) 2000-06-23 2010-03-09 Teva Pharmaceutical Industries Ltd. Rapidly expanding composition for gastric retention and controlled release of therapeutic agents, and dosage forms including the composition
US6881420B2 (en) 2000-06-23 2005-04-19 Teva Pharmaceutical Industries Ltd. Compositions and dosage forms for gastric delivery of irinotecan and methods of treatment that use it to inhibit cancer cell proliferation
DE50014547D1 (de) * 2000-09-01 2007-09-20 Cognis Ip Man Gmbh Mund- und Zahnpflegemittel
JP4820024B2 (ja) * 2001-01-10 2011-11-24 昭和薬品化工株式会社 局所麻酔用組成物
JP5089840B2 (ja) * 2001-09-25 2012-12-05 救急薬品工業株式会社 ニコチン含有フィルム製剤
WO2003039465A2 (en) * 2001-11-05 2003-05-15 Orahealth Corporation Treating canker sores with patches to speed healing and relieve pain
WO2004080399A2 (en) * 2003-03-12 2004-09-23 Epitome Pharmaceuticals Limited Rapidly absorbing lipophilic skin compositions and uses therefor
US20040185009A1 (en) * 2003-03-19 2004-09-23 Dexcel Pharma Technologies Ltd. Composition and device for treating periodontal diseases
BRPI0415741B1 (pt) 2003-11-07 2013-07-23 composições de tabaco e métodos de fabricação de uma composição de tabaco
US8627828B2 (en) 2003-11-07 2014-01-14 U.S. Smokeless Tobacco Company Llc Tobacco compositions
WO2005048965A2 (en) * 2003-11-13 2005-06-02 Wm. Wrigley Jr. Company Method and composition for breath freshening
KR101201638B1 (ko) 2004-04-23 2012-11-15 암젠 인코포레이티드 서방성 제형
CA2649149A1 (en) * 2006-04-11 2007-10-25 Koko Kosmetikvertrieb Gmbh & Co. Kg Nanoparticle containing nicotine and/or cotinine, dispersions, and use thereof
US8642088B2 (en) 2009-09-04 2014-02-04 Wisconsin Alumni Research Foundation Tannin-chitosan composites
KR101307367B1 (ko) * 2010-09-14 2013-09-25 주식회사 이노테라피 탄닌, 폴리에틸렌글리콜 및 물, 저급 알코올 또는 이들의 혼합물을 포함하는 접착제 조성물
US8865198B2 (en) 2010-10-25 2014-10-21 Dexcel Pharma Technologies Ltd. Method for treating a periodontal disease
FR2972327B1 (fr) * 2011-03-11 2017-08-11 Laboratoires Le Stum Composition nutraceutique mucoadhesive comprenant une association d'antioxydants
GB2496654A (en) * 2011-11-18 2013-05-22 Reckitt & Colman Overseas Self-assembling peptides
US20130158132A1 (en) * 2011-12-19 2013-06-20 Aida Salatinjants Formulation Solution Adapted To Prolong Plasma Times Of Drugs In Mammals Including Humans
WO2015167257A1 (ko) * 2014-04-29 2015-11-05 포항공과대학교 산학협력단 구강 도포용 조성물 및 그 제조 방법
RU2606589C2 (ru) * 2015-02-16 2017-01-10 Александр Александрович Кролевец Способ получения нанокапсул танина
US10532046B2 (en) * 2015-12-03 2020-01-14 Niconovum Usa, Inc. Multi-phase delivery compositions and products incorporating such compositions
US20220287981A1 (en) * 2019-08-16 2022-09-15 Amd Pharma Ltd. Adhesive drug delivery microparticles and a product comprising thereof
CN115477920A (zh) * 2021-06-15 2022-12-16 西南大学 一种单宁酸基水下粘合剂制备方法及制品
KR20230146888A (ko) 2022-04-13 2023-10-20 경북대학교 산학협력단 치아 수복을 위한 약물 서방성 자가 치유 코팅층 및 이의 제조방법

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB104609A (en) * 1916-06-05 1917-03-15 Monneron & Guye A Method of Manufacturing a Medicinal Aluminium Preparation.
GB918754A (en) * 1959-08-14 1963-02-20 Armour & Co Improvements in or relating to corticotrophin preparations
GB2036750B (en) * 1978-11-23 1983-05-05 Payne M Tannin complexes
JPS5846011A (ja) * 1981-09-14 1983-03-17 Kao Corp 毛髪処理剤
JPH01166763A (ja) * 1987-12-22 1989-06-30 Nitta Gelatin Inc 医科用および歯科用硬化性材料
WO1989010745A1 (en) * 1988-05-02 1989-11-16 Pomerantz, Edwin Compositions and in situ methods for forming films on body tissue
JPH04114655A (ja) * 1990-09-03 1992-04-15 Shinonaga Kasei Kk 医療用硬化組成物
JPH04312522A (ja) * 1991-04-08 1992-11-04 Yoshiaki Kawashima 徐放性錠剤の製造方法
JP3496727B2 (ja) * 1993-12-27 2004-02-16 救急薬品工業株式会社 製剤用基剤
JPH08319232A (ja) * 1995-03-22 1996-12-03 Takeda Chem Ind Ltd 粉粒状組成物
JP2885668B2 (ja) * 1995-09-29 1999-04-26 沢井製薬株式会社 テプレノン製剤

Also Published As

Publication number Publication date
JP2001510788A (ja) 2001-08-07
CA2296654A1 (en) 1999-02-04
NO20000284D0 (no) 2000-01-20
WO1999004764A1 (en) 1999-02-04
KR20010021911A (ko) 2001-03-15
EP1003483A1 (en) 2000-05-31
AU8578498A (en) 1999-02-16
HUP0002490A2 (hu) 2000-12-28
NO20000284L (no) 2000-03-22
BR9811478A (pt) 2000-08-15

Similar Documents

Publication Publication Date Title
IL134151A0 (en) Tannic acid-polymer compositions for controlled release of pharmaceutical agents, particularly in the oral cavity
IL123986A0 (en) Antithombotic agents process for their preparation and pharmaceutical compositions comprising them
HUP0201376A2 (en) Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds
HU9800985D0 (en) Retarde polymere compositions for pharmaceutical compositions
EG23875A (en) Oral pharmaceutical pulsed release dosage form
HUP0203542A3 (en) 3(5)-amino-pyrazole derivatives, process for their preparation, their use and pharmaceutical compositions containing the same
IL138280A0 (en) 20-KETO-11β-ARYLSTERIODS, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
EP1043031A4 (en) MEDICINAL COMPOSITIONS WITH PROLONGED RELEASE
HUP0204519A3 (en) 4,5-dihydro-1h-pyrazole derivatives having cb1-antagonistic activity, pharmaceutical compositions containing them and process for their preparations
IL136938A0 (en) 11β-HALOGEN-7α-SUBSTITUTED ESTRATRIENES, PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AND METHODS FOR THE PREPARATION THEREOF
ZA986889B (en) Controlled release pharmaceutical compositions containing tiagabine
GB9713149D0 (en) Pharmaceutical formulations
HUP0001555A3 (en) Tetrahydro-imidazo-naphthyridine derivatives, pharmaceutical compositions thereof and process for their preparation
HUP0202762A3 (en) Solid lipid compositions, process for their preparation and use thereof
AP2000002010A0 (en) Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
HUP0102215A3 (en) Benzoylpyridazines, pharmaceutical compositions containing the same and process for their preparation
HUP0201402A3 (en) Bis-sulfonamides, process for their preparation and pharmaceutical compositions containing them
HUP9803040A3 (en) Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them
HUP0105308A3 (en) Eletriptan hydrobromide monohydrate, process for its preparation and pharmaceutical compositions containing the same
HUP0104544A2 (en) New pharmaceutical composition and the process for its preparation
ZA99168B (en) Pharmaceutical formulations and processes for their preparation.
HUP9803041A3 (en) Thiazole derivatives, process for the preparation thereof, use thereof and pharmaceutical compositions containing them
HUP0004132A3 (en) Rapidly soluble drug composition
ZA983205B (en) Sustained release compositions and the process for their preparation
HUP0001234A3 (en) Pharmaceutical composition for the programmed release of dexfenfluramine